Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study

New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion

Exact Sciences Announces Second-Quarter 2024 Results

Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening

Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO® 

Exact Sciences Earns 2024 Great Place To Work^® Certification^™

Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy

Exact Sciences Announces First-Quarter 2024 Results

Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW^® 2024

Exact Sciences Names Aaron Bloomer as New Chief Financial Officer

Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024 

Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-cancer